Early Tecovirimat Treatment for Mpox Disease Among People With HIV
This cohort study examines whether staring tecovirimat within 7 days of mpox symptom onset is associated with a lower rate of mpox disease progression among people with HIV.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research
More News: Internal Medicine | Study